Insider · CIK 0001202098
Stelios Papadopoulos
Files at: EXEL, RGLS, BIIB, BGMD. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 SForm 4 → | Feb 22, 7:35 pm EST | EXELIXIS, INC.EXEL | 26,250 | $21.25 | $557,813 | 1,042,251 | −2.46% | plan? |
| Feb 21, 2019 MForm 4 → | Feb 22, 7:35 pm EST | EXELIXIS, INC.EXEL | 26,250 | $4.39 | $115,350 | 1,068,501 | — | plan? |
| Dec 28, 2018 PForm 4 → | Jan 2, 2019, 4:12 pm EST | Regulus Therapeutics Inc.RGLS | 50,000 | $1.09 | $54,570 | 835,073 | +6.37% | plan? |
| Dec 26, 2018 PForm 4 → | Dec 28, 4:21 pm EST | Regulus Therapeutics Inc.RGLS | 116,401 | $0.9737 | $113,338 | 785,073 | +17.4% | plan? |
| Nov 15, 2018 PForm 4 → | Nov 19, 4:03 pm EST | Regulus Therapeutics Inc.RGLS | 500,000 | $1.36 | $680,550 | 668,672 | +296% | plan? |
| Nov 12, 2018 AForm 4 → | Nov 21, 5:29 pm EST | Regulus Therapeutics Inc.RGLS | 20,910 | — | — | 168,672 | — | plan? late |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:27 pm EDT | BIOGEN INC.BIIB | 1,450 | — | — | 3,190 | — | plan? |
| May 24, 2018 AForm 4 → | May 24, 8:28 pm EDT | EXELIXIS, INC.EXEL | 7,937 | — | — | 1,042,251 | — | plan? |
| May 7, 2018 SForm 4 → | May 7, 8:07 pm EDT | EXELIXIS, INC.EXEL | 15,000 | $22.15 | $332,250 | 1,034,314 | −1.43% | plan? |
| May 7, 2018 MForm 4 → | May 7, 8:07 pm EDT | EXELIXIS, INC.EXEL | 15,000 | $11.66 | $174,900 | 1,049,314 | — | plan? |
| Mar 2, 2018 SForm 4 → | Mar 2, 8:03 pm EST | EXELIXIS, INC.EXEL | 15,000 | $24.05 | $360,750 | 1,034,314 | −1.43% | plan? |
| Mar 2, 2018 MForm 4 → | Mar 2, 8:03 pm EST | EXELIXIS, INC.EXEL | 15,000 | $7.97 | $119,550 | 1,049,314 | — | plan? |
| Dec 4, 2017 AForm 4 → | Dec 6, 7:41 pm EST | Regulus Therapeutics Inc.RGLS | 96,629 | $0.89 | $86,000 | 1,797,306 | — | plan? |
| Sep 22, 2017 SForm 4 → | Sep 22, 7:07 pm EDT | EXELIXIS, INC.EXEL | 10,000 | $25.40 | $254,000 | 0 | −100% | plan? |
| Sep 18, 2017 SForm 4 → | Sep 20, 6:48 pm EDT | EXELIXIS, INC.EXEL | 200,000 | $27.68 | $5,535,387 | 1,034,314 | −16.2% | plan? |
| Jul 25, 2017 PForm 4 → | Jul 25, 6:06 pm EDT | Regulus Therapeutics Inc.RGLS | 1,000,000 | $0.91 | $910,000 | 1,770,677 | +130% | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:52 pm EDT | BIOGEN INC.BIIB | 1,740 | — | — | 19,946 | — | plan? |
| May 25, 2017 AForm 4/A → | May 30, 7:55 pm EDT | EXELIXIS, INC.EXEL | 5,843 | — | — | 1,234,314 | — | plan? |
| May 25, 2017 AForm 4 → | May 26, 8:49 pm EDT | EXELIXIS, INC.EXEL | 5,843 | — | — | 1,234,314 | — | plan? amended |
| Mar 21, 2017 PForm 4 → | Mar 23, 4:26 pm EDT | Regulus Therapeutics Inc.RGLS | 500,000 | $1.22 | $607,900 | 700,677 | +249% | plan? |
| Mar 20, 2017 SForm 4 → | Mar 21, 7:28 pm EDT | EXELIXIS, INC.EXEL | 10,000 | $21.66 | $216,600 | 1,228,471 | −0.81% | plan? |
| Mar 20, 2017 MForm 4 → | Mar 21, 7:28 pm EDT | EXELIXIS, INC.EXEL | 10,000 | $10.53 | $105,300 | 1,238,471 | — | plan? |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:43 pm EDT | BIOGEN INC.BIIB | 1,590 | — | — | 18,170 | — | plan? |
| Jan 4, 2016 AForm 4 → | Jan 5, 7:55 pm EST | EXELIXIS, INC.EXEL | 15,071 | — | — | 1,228,471 | — | plan? |
| Aug 7, 2015 MForm 4 → | Aug 7, 6:05 pm EDT | Regulus Therapeutics Inc.RGLS | 50,677 | $1.55 | $78,801 | 200,677 | — | plan? |
| Jul 27, 2015 PForm 4 → | Jul 27, 5:03 pm EDT | BIOGEN INC.BIIB | 10,000 | $304.88 | $3,048,775 | 5,000 | — | plan? |
| Jun 10, 2015 AForm 4 → | Jun 11, 4:33 pm EDT | BIOGEN INC.BIIB | 1,040 | — | — | 16,580 | — | plan? |